September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Mesenchymal stem cell-like pericytes inhibit pathological retinal neovascularization in ischemic retinopathy
Author Affiliations & Notes
  • Harumasa Yokota
    Ophthalmology, Asahikawa Medical University, Asahikawa, Hokkaido, Japan
  • Akito Shimouchi
    Ophthalmology, Asahikawa Medical University, Asahikawa, Hokkaido, Japan
  • Chiemi Matsumoto
    Ophthalmology, Asahikawa Medical University, Asahikawa, Hokkaido, Japan
  • Maki Kabara
    CardioVascular Innovation and Regeneration, Asahikawa Medical University, Asahikawa, Japan
  • Jun-ichi Kawabe
    CardioVascular Innovation and Regeneration, Asahikawa Medical University, Asahikawa, Japan
  • Taiji Nagaoka
    Ophthalmology, Asahikawa Medical University, Asahikawa, Hokkaido, Japan
  • Akitoshi Yoshida
    Ophthalmology, Asahikawa Medical University, Asahikawa, Hokkaido, Japan
  • Footnotes
    Commercial Relationships   Harumasa Yokota, None; Akito Shimouchi, None; Chiemi Matsumoto, None; Maki Kabara, None; Jun-ichi Kawabe, None; Taiji Nagaoka, None; Akitoshi Yoshida, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 5318. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Harumasa Yokota, Akito Shimouchi, Chiemi Matsumoto, Maki Kabara, Jun-ichi Kawabe, Taiji Nagaoka, Akitoshi Yoshida; Mesenchymal stem cell-like pericytes inhibit pathological retinal neovascularization in ischemic retinopathy. Invest. Ophthalmol. Vis. Sci. 2016;57(12):5318.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Recently, it has been reported that some populations of pericytes (PCs) have function as mesenchymal stem cells (MSCs). The aim of this study was to investigate therapeutic potential of MSC-like PCs in a murine model of ischemic retinopathy.

Methods : We isolated MSC-like PCs from subcutaneous adipose of 8 weeks old transgenic mice harboring eGFP by using specific two markers. Oxygen-induced retinopathy (OIR) was induced by exposing C57BL/6J mice to 75% oxygen from postnatal 7 days (P7) to P12 followed by return to room air. MSC-like PCs or PCs were intravitreally injected into the right eyes at P12. The left eyes were kept as a control. Retinal vasculature was examined immunohistochemically using retinal wholemounts labeled with isolectin B4. The area of abnormalities was expressed as the ratio to total retinal area (mean ± SE).

Results : OIR caused a robust increase of non-perfused area (NPA)(27.1±2.1%) and retinal neovascularization (NV)(27.7±0.9%). Injected MSC-like PCs incorporated into the retina, and some resided along the vasculatures. MSC-like PCs treatment significantly reduced NPA (3.5±0.8%, p<0.01 vs. OIR) and NV (4.2±1.0%, p<0.01 vs. OIR) at P17. In contrast, there were few injected PCs that existed along the retinal vasculatures at P17. However, PCs treatment also resulted in a reduction of NPA (8.6±1.4%, p<0.01 vs. OIR) and NV (13.2±1.9%, p<0.01 vs. OIR).

Conclusions : Intravitreal injection of MSC-like PCs prevents pathological angiogenesis and accelerates physiological revascularization in OIR. These effects may be caused by release of cytokines from MSC-like PCs. A further work is needed to understand the mechanism for these beneficial effects of MSC-like PCs and differences between MSC-like PCs and PCs.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×